Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components

BACKGROUND: Platelet transfusion carries risk of transfusion‐transmitted infection (TTI). Pathogen reduction of platelet components (PRPC) is designed to reduce TTI. Pulmonary adverse events (AEs), including transfusion‐related acute lung injury and acute respiratory distress syndrome (ARDS) occur w...

Descripción completa

Detalles Bibliográficos
Autores principales: Snyder, Edward L., Wheeler, Allison P., Refaai, Majed, Cohn, Claudia S., Poisson, Jessica, Fontaine, Magali, Sehl, Mary, Nooka, Ajay K., Uhl, Lynne, Spinella, Philip, Fenelus, Maly, Liles, Darla, Coyle, Thomas, Becker, Joanne, Jeng, Michael, Gehrie, Eric A., Spencer, Bryan R., Young, Pampee, Johnson, Andrew, O'Brien, Jennifer J., Schiller, Gary J., Roback, John D., Malynn, Elizabeth, Jackups, Ronald, Avecilla, Scott T., Lin, Jin‐Sying, Liu, Kathy, Bentow, Stanley, Peng, Ho‐Lan, Varrone, Jeanne, Benjamin, Richard J., Corash, Laurence M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Transfusion Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544211/
https://www.ncbi.nlm.nih.gov/pubmed/35748490
http://dx.doi.org/10.1111/trf.16987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544211/
https://www.ncbi.nlm.nih.gov/pubmed/35748490
http://dx.doi.org/10.1111/trf.16987

Ejemplares similares